T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered donor cells take aim at stubborn childhood leukemia
Disease control Recruiting nowThis early-phase study tests a treatment called BEAM-201, made from donor immune cells engineered to attack cancer cells in people with T-cell acute lymphoblastic leukemia or lymphoma that has returned or not responded to standard therapy. Up to 33 children and young adults (ages…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Supercharging immune cells to fight blood cancer
Disease control Recruiting nowThis study tests a new treatment for people with certain blood cancers, like leukemia and MDS. Doctors take a patient's own immune cells, modify them in a lab to recognize unique markers on their cancer cells, and then give them back. The goal is to see if this personalized thera…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC